Topoisomerase I inhibitors: topotecan and irenotecan
- 1 January 1994
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 20 (1), 73-96
- https://doi.org/10.1016/0305-7372(94)90011-6
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- DNA Topoisomerases as Anticancer Drug TargetsPublished by Elsevier ,1990
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase geneCell, 1987
- Localization of specific topoisomerase I interactions within the transcribed region of active heat shock genes by using the inhibitor camptothecin.Molecular and Cellular Biology, 1987
- Topoisomerase I interacts with transcribed regions in Drosophila cellsCell, 1986
- Characterisation of size variants of type I DNA topoisomerase isolated from calf thymusEuropean Journal of Biochemistry, 1984
- Camptothecin effects on DNA synthesis in murine leukemia cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1972
- Selective Interruption of High Molecular Weight RNA Synthesis in HeLa Cells by CamptothecinNature New Biology, 1972
- Effects of camptothecin on RNA synthesis in leukemia L1210 cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1971
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966